Stockholders' Equity - Narrative (Details) - USD ($)				1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 12, 2024	Aug. 07, 2024	Jun. 19, 2021	May 31, 2024	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Jan. 07, 2025	Dec. 31, 2024	Sep. 12, 2024	Apr. 05, 2024	Aug. 09, 2023	Dec. 15, 2022	Aug. 05, 2020
Class of Stock [Line Items]
Dividends payable, amount (per share)					$ 0.05
Preferred stock issued (in shares)					0		0			0
Options, grant (in shares)							0
Stock based compensation for stock options					$ 22,000	$ 53,000	$ 67,000	$ 159,000
Net of estimated forfeitures percentage							19.00%
Weighted average estimated fair value, vested (in dollars per share)								$ 1.24
Share price (in dollars per share)					$ 14.70		$ 14.70
Proceeds from exercise of stock options							$ 64,591	$ 0
Exercise of stock options (in shares)							28,757	0
Purchase of common stock (in shares)							23,564
Estimated fair value of unamortized compensation (in shares)					119,967		119,967
Stock option awards					$ 13,000		$ 13,000
Remaining weighted-average vesting period							1 year 3 months 7 days
Stock based compensation for grants totataling					398,000	306,000	$ 1,148,000	$ 747,000
Unamortized compensation cost					1,496,376		$ 1,496,376
Unamortized compensation cost, period for recognition							1 year 10 months 28 days
Maximum share purchase under ESPP			750,000
Purchase shares of common stock (in shares)			5,000
Stock-based compensation expense					10,000	$ 0	$ 26,000	$ 0
Warrants issued to purchase common stock (in shares)							969,525
Common stock shares authorized					$ 993,200		$ 993,200
Warrants, term														36 months 15 days
Warrants, extended term											21 months 15 days
Class of warrant exercise price (in dollars per share)					$ 1.00		$ 1.00
Warrants exercised (in shares)							394,525	0
Stock Issued warrant exercised (in shares)							371,634
Warrant or right, outstanding (in shares)					247,500		247,500
Equity and debt securities registration amount												$ 50,000,000
Aggregate offering price for ATM program									$ 25,000,000
Net proceeds from issuance of common stock							$ 9,470,453	$ 9,066,098
2014 Equity Participation Plan
Class of Stock [Line Items]
Common shares authorized for grant under the Plan (in shares)	700,000												1,900,000		1,400,000
Expiration period	10 years
Number of options, granted (in shares)							0
2014 Equity Participation Plan | Options Granted to 10% Shareholder
Class of Stock [Line Items]
Expiration period	5 years
2014 Equity Participation Plan | Non-Statutory Stock Options
Class of Stock [Line Items]
Expiration period	10 years
2024 Equity Participation Plan
Class of Stock [Line Items]
Common shares authorized for grant under the Plan (in shares)		1,000,000
Expiration period		10 years
Options, grant (in shares)							199,515
Number of options, granted (in shares)							0
2024 Equity Participation Plan | Options Granted to 10% Shareholder
Class of Stock [Line Items]
Expiration period	5 years
2024 Equity Participation Plan | Non-Statutory Stock Options
Class of Stock [Line Items]
Expiration period	10 years
ATM Program
Class of Stock [Line Items]
Offering price				$ 16,400,000
Stock sold (in shares)							612,999
Shares sold, weighted average price per share (in dollars per share)							$ 16.00
Net proceeds from issuance of common stock							$ 9,464,323
Remaining capacity to sell additional common stock					$ 15,945,937		$ 15,945,937